Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/6630Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Mogilaiah, K | - |
| dc.contributor.author | Vidya, K | - |
| dc.date.accessioned | 2009-11-18T07:43:10Z | - |
| dc.date.available | 2009-11-18T07:43:10Z | - |
| dc.date.issued | 2006-08 | - |
| dc.identifier.issn | 0975-0983(Online); 0376-4699(Print) | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/6630 | - |
| dc.description | 1905-1908 | en_US |
| dc.description.abstract | Condensation of (2-oxo-3-phenyl-2H-[1,8]naphthyridin-1-yl)-acetic acid hydrazide 2 with different acetophenones yields the corresponding acetophenone (2-oxo-3-phenyl-2H-[1,8]naphthyridin-1-yl)methylcarbonyl hydrazones 3, which on treatment with acetic anhydride affords the respective 1-(4-acetyl-5-aryl-5-methyl-[1,3,4]oxadiazol-2-ylmethyl)-3-phenyl-1H-[1,8]naphthyridin-2-ones 4. The structures of the compounds 3 and 4 have been confirmed on the basis of analytical and spectral data. The compounds 4 have been screened for their antibacterial activity. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | CSIR | en_US |
| dc.relation.ispartofseries | Int. Cl.8 C07D | en_US |
| dc.source | IJC-B Vol.45B(08) [August 2006] | en_US |
| dc.subject | 1,8-Naphthyridinyl acetic acid hydrazide | en_US |
| dc.subject | acetophenones | en_US |
| dc.subject | condensation | en_US |
| dc.subject | 1,8-naphthyridinyl methylcarbonyl hydrazones acetic anhydride | en_US |
| dc.subject | cyclization | en_US |
| dc.subject | 1,3,4-oxadiazolyl-1, 8-naphthyridines | en_US |
| dc.title | Synthesis and antibacterial activity of 1,3,4-oxadiazolyl-1,8-naphthyridines | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | IJC-B Vol.45B(08) [August 2006] | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJCB 45B(8) 1905-1908.pdf | 42.11 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.